These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 1388088)
1. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Relton JK; Rothwell NJ Brain Res Bull; 1992 Aug; 29(2):243-6. PubMed ID: 1388088 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-1beta and the interleukin-1 receptor antagonist act in the striatum to modify excitotoxic brain damage in the rat. Lawrence CB; Allan SM; Rothwell NJ Eur J Neurosci; 1998 Mar; 10(3):1188-95. PubMed ID: 9753187 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-1 receptor antagonist inhibits neuronal damage caused by fluid percussion injury in the rat. Toulmond S; Rothwell NJ Brain Res; 1995 Feb; 671(2):261-6. PubMed ID: 7743213 [TBL] [Abstract][Full Text] [Related]
4. Excitotoxic brain damage in the rat induces interleukin-1beta protein in microglia and astrocytes: correlation with the progression of cell death. Pearson VL; Rothwell NJ; Toulmond S Glia; 1999 Feb; 25(4):311-23. PubMed ID: 10028914 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures. Hailer NP; Vogt C; Korf HW; Dehghani F Eur J Neurosci; 2005 May; 21(9):2347-60. PubMed ID: 15932594 [TBL] [Abstract][Full Text] [Related]
6. Delayed administration of interleukin-1 receptor antagonist protects against transient cerebral ischaemia in the rat. Mulcahy NJ; Ross J; Rothwell NJ; Loddick SA Br J Pharmacol; 2003 Oct; 140(3):471-6. PubMed ID: 12970087 [TBL] [Abstract][Full Text] [Related]
7. Dual effects of interleukin-1beta on N-methyl-D-aspartate-induced retinal neuronal death in rat eyes. Kido N; Inatani M; Honjo M; Yoneda S; Hara H; Miyawaki N; Honda Y; Tanihara H Brain Res; 2001 Aug; 910(1-2):153-62. PubMed ID: 11489265 [TBL] [Abstract][Full Text] [Related]
8. Corticotrophin-releasing factor antagonist inhibits neuronal damage induced by focal cerebral ischaemia or activation of NMDA receptors in the rat brain. Strijbos PJ; Relton JK; Rothwell NJ Brain Res; 1994 Sep; 656(2):405-8. PubMed ID: 7820601 [TBL] [Abstract][Full Text] [Related]
9. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia. Dawson DA; Graham DI; McCulloch J; Macrae IM Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111 [TBL] [Abstract][Full Text] [Related]
10. Role and mechanisms of interleukin-1 in the modulation of neurotoxicity. Ma XC; Gottschall PE; Chen LT; Wiranowska M; Phelps CP Neuroimmunomodulation; 2002-2003; 10(4):199-207. PubMed ID: 12584407 [TBL] [Abstract][Full Text] [Related]
11. Lipocortin-1 inhibits NMDA receptor-mediated neuronal damage in the striatum of the rat. Black MD; Carey F; Crossman AR; Relton JK; Rothwell NJ Brain Res; 1992 Jul; 585(1-2):135-40. PubMed ID: 1387336 [TBL] [Abstract][Full Text] [Related]
12. Cortical protection by localized striatal injection of IL-1ra following cerebral ischemia in the rat. Stroemer RP; Rothwell NJ J Cereb Blood Flow Metab; 1997 Jun; 17(6):597-604. PubMed ID: 9236716 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective effects of human recombinant interleukin-1 receptor antagonist in focal cerebral ischaemia in the rat. Loddick SA; Rothwell NJ J Cereb Blood Flow Metab; 1996 Sep; 16(5):932-40. PubMed ID: 8784237 [TBL] [Abstract][Full Text] [Related]
14. Exacerbation of ischemic brain damage by localized striatal injection of interleukin-1beta in the rat. Stroemer RP; Rothwell NJ J Cereb Blood Flow Metab; 1998 Aug; 18(8):833-9. PubMed ID: 9701344 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome-proliferator-activated receptors gamma and peroxisome-proliferator-activated receptors beta/delta and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain. Glatz T; Stöck I; Nguyen-Ngoc M; Gohlke P; Herdegen T; Culman J; Zhao Y J Hypertens; 2010 Jul; 28(7):1488-97. PubMed ID: 20410836 [TBL] [Abstract][Full Text] [Related]
16. Intracerebroventricular administration of a specific IL-1 receptor antagonist blocks food and water intake suppression induced by interleukin-1 beta. Plata-Salamán CR; Ffrench-Mullen JM Physiol Behav; 1992 Jun; 51(6):1277-9. PubMed ID: 1386466 [TBL] [Abstract][Full Text] [Related]
17. Hypothalamic dopamine release and local cerebral blood flow during onset of heatstroke in rats. Kao TY; Chio CC; Lin MT Stroke; 1994 Dec; 25(12):2483-6; discussion 2486-7. PubMed ID: 7974593 [TBL] [Abstract][Full Text] [Related]
18. Delayed treatment with YM90K, an AMPA receptor antagonist, protects against ischaemic damage after middle cerebral artery occlusion in rats. Kawasaki-Yatsugi S; Shimizu-Sasamata M; Yatsugi S; Yamaguchi T J Pharm Pharmacol; 1998 Aug; 50(8):891-8. PubMed ID: 9751454 [TBL] [Abstract][Full Text] [Related]
19. Interleukin-1 receptor antagonist attenuates the heat stroke-induced neuronal damage by reducing the cerebral ischemia in rats. Lin MT; Kao TY; Jin YT; Chen CF Brain Res Bull; 1995; 37(6):595-8. PubMed ID: 7670883 [TBL] [Abstract][Full Text] [Related]
20. Role of endogenous interleukin-1 receptor antagonist in regulating fever induced by localised inflammation in the rat. Cartmell T; Luheshi GN; Hopkins SJ; Rothwell NJ; Poole S J Physiol; 2001 Feb; 531(Pt 1):171-80. PubMed ID: 11179401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]